{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-052242","form_type":"8-K","ticker":"KYNB","cik":"0000921299","company_name":"KYNTRA BIO, INC.","filed_at":"2023-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.411932+00:00","generated_at":"2026-06-10T03:43:58.816233+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"FibroGen appoints Thane Wettig as permanent CEO and Board member, effective Oct 2, 2023","bullets":["Thane Wettig promoted from Interim CEO to CEO and Board member as of Oct 2, 2023.","Mr. Wettig had served as Interim CEO since July 23, 2023.","Appointed as Class I director with term expiring at 2024 annual meeting.","Compensation terms remain per prior 8-K filed July 25, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-052242","json":"https://secwatch.observer/filing/0000950170-23-052242.json","markdown":"https://secwatch.observer/filing/0000950170-23-052242.md","text":"https://secwatch.observer/filing/0000950170-23-052242.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/921299/000095017023052242/0000950170-23-052242-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/921299/000095017023052242/fgen-20231002.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T03:43:58.816233+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"99818df578","claim":"Thane Wettig was appointed as Chief Executive Officer at KYNTRA BIO, INC..","evidence_excerpt":"On October 2, 2023, the Board of Directors (the “Board”) of FibroGen, Inc. (the “Company”) appointed Interim Chief Executive Officer Thane Wettig as (i) Chief Executive Officer and (ii) a member of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/921299/000095017023052242/0000950170-23-052242-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}